Related Experiment Video
Updated: May 20, 2025

Optimized Management of Endovascular Treatment for Acute Ischemic Stroke
Published on: January 18, 2018
Guideline-Directed Medical Therapy and Outcomes in the ISCHEMIA Trial
David J Maron1, Jonathan D Newman2, Rebecca Anthopolos3
1Department of Medicine, Stanford Prevention Research Center and Division of Cardiovascular Medicine, Stanford University School of Medicine, Stanford, California, USA.
Insights
Achieving guideline-directed medical therapy (GDMT) goals for chronic coronary disease (CCD) is linked to fewer cardiovascular events. Early and sustained attainment of goals, particularly systolic blood pressure, significantly reduces risks.
Area of Science:
- Cardiology
- Preventive Medicine
- Clinical Research
Background:
- Guideline-directed medical therapy (GDMT) is recommended for chronic coronary disease (CCD) patients, but achieving all goals is uncommon.
- The impact of achieving specific GDMT goals and their timing on cardiovascular events remains uncertain.
Purpose of the Study:
- To investigate the relationship between achieving specific GDMT goals and clinical outcomes in patients with CCD.
- To determine the relative importance and timing of GDMT goal attainment for cardiovascular event reduction.
Main Methods:
- Observational study of 5,179 participants with CCD from the ISCHEMIA trial.
- Primary outcome: cardiovascular death or myocardial infarction (MI).
- GDMT goals included systolic blood pressure (SBP) <130 mmHg, LDL-C <70 mg/dL, smoking cessation, and antiplatelet therapy.
- Bayesian joint modeling analyzed longitudinal goal status and time-to-event data.
Main Results:
- Only 12% of participants met all 4 GDMT goals at baseline.
- Achieving all 4 GDMT goals at baseline was associated with an 8.7% 4-year cumulative event rate for CV death/MI, versus 24.5% for no goals met.
- Systolic blood pressure (SBP) goal attainment showed a significant absolute event reduction (-5.1%), and each 10 mmHg lower SBP was linked to a 10% relative risk reduction in CV death/MI.
Conclusions:
- Early attainment and maintenance of GDMT goals, especially SBP control, are associated with reduced cardiovascular events in CCD patients.
- Meeting all 4 GDMT goals at baseline was associated with an absolute 16% reduction in CV deaths and MIs compared to meeting none.
Background:
Guideline-directed medical therapy (GDMT) with multiple risk factor goals is recommended for patients with chronic coronary disease (CCD), yet achieving all GDMT goals is uncommon. The relative importance of these goals and timing of their attainment on cardiovascular events is uncertain.
Objectives:
This study aims to describe the relationship between achieving specific GDMT goals, when they are achieved, and clinical outcomes.
Methods:
This was an observational study of participants with CCD in the ISCHEMIA (International Study of Comparative Health Effectiveness with Medical and Invasive Approaches) trial. The primary outcome was cardiovascular (CV) death or myocardial infarction (MI). GDMT goals were systolic blood pressure (SBP) <130 mm Hg, low-density lipoprotein cholesterol <70 mg/dL, not smoking, and antiplatelet therapy. Frequency of GDMT goals met at baseline and during follow-up is described. Bayesian joint modeling for longitudinal goal status and time-to-event analyses characterized the relative importance of specific GDMT goal attainment and timing with CV death/MI.
Results:
All 5,179 ISCHEMIA participants were included. Among 4,914 participants with complete data on all 4 GDMT goals at baseline, 386 (9%), 2,073 (42%), 1,843 (38%), and 612 (12%) met 0-1, 2, 3, and 4 GDMT goals, respectively. The 4-year cumulative event rate for CV death/MI was highest for participants who attained no GDMT goals (24.5%; 95% credible interval [CrI]: 13.5%-42.2%) and lowest for those who attained all goals at baseline and remained at goal during follow-up (8.7%; 95% CrI: 6.7%-10.9%). SBP goal attainment was associated with a significant absolute event reduction in CV death/MI (-5.1%; 95% CrI: -11.3% to -1.0%), followed by antiplatelet therapy (-11.2%; 95% CrI: -29.1% to 0.8%), achieving low-density lipoprotein cholesterol <70 mg/dL (-2.0%; 95% CrI: -6.0% to 2.4%), and not smoking (-1.7%; 95% CrI: -9.3% to 4.2%). Ten millimeters of mercury lower SBP during follow-up was associated with 10% relative risk reduction of CV death/MI (RR [relative risk] = 0.90; 95% CrI: 0.82-0.98), after adjusting for other GDMT goals and baseline characteristics.
Conclusions:
Among participants with CCD, early attainment and maintenance of GDMT goals, especially SBP, were associated with fewer cardiovascular events. Compared with no GDMT goals at target, having all 4 GDMT goals at target at baseline was associated with an absolute 16% fewer CV deaths and MIs. (ISCHEMIA [International Study of Comparative Health Effectiveness With Medical and Invasive Approaches]; NCT01471522).
More Related Videos
10:28Interventional Diagnostic Procedure: A Practical Guide for the Assessment of Coronary Vascular Function
Published on: March 15, 2022
05:41Left Anterior Descending Coronary Artery Ligation for Ischemia-Reperfusion Research: Model Improvement via Technical Modifications and Quality Control
Published on: December 16, 2022
Related Concept Videos
Ischemic Heart Disease: Overview
Atherosclerosis, the primary malefactor, orchestrates this dangerous condition. It manifests as the accumulation of fatty deposits, akin to insidious plaques, within arterial walls. As time elapses, these plaques metamorphose, hardening and...
Diabetes: Management and Pharmacotherapy
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
Antianginal Drugs: Calcium Channel Blockers and Ranolazine
CCBs, a diverse class that includes dihydropyridines (nifedipine) and diphenylalkylamines (verapamil and diltiazem), exert their effect by blocking calcium channels in cardiac and smooth muscle cells. This...
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System